Information for Patients
Each patient's cancer is as unique as the human fingerprint. Cancer is caused by complex genetic changes occurring in normal cells. Cancer treatment therapies depend upon accurately identifying and evaluating these complex genetic changes, many of which can be analyzed with appropriate laboratory testing.
Exiqon Diagnostics offers a wide variety of cancer testing services. Exiqon Diagnostics' laboratory tests can help the oncologist answer specific questions about a patient's cancer, such as:
- Is the tumor malignant?
- What type of cancer is it?
- How aggressive is the cancer?
- Is it likely to recur?
- To which drugs is the tumor resistant?
Providing answers to the above questions can help oncologists in planning treatment. Exiqon Diagnostics' mission is to provide personalized cancer therapy testing for the benefit of cancer patients. Our cancer testing services assist physicians in answering critical molecular and cellular-based questions that can improve the cancer patient's outcome, survival and quality of life. For over 20 years, Exiqon Diagnostics has performed state-of-the-art cancer testing services for over 100,000 patients worldwide. As a result, these patients have benefited from specialized therapy designed for their unique cancer
Please ask your doctor about the Oncotech EDR Assay and our prognostic and predictive molecular marker assays. Further information is available on this website or a local Exiqon Diagnostics representative can meet with your doctor to answer any questions they may have about our available cancer testing services.
For more information: